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1. INTRODUCTION 
Pharmaceutical Analysis(1-2) is the branch of chemistry involved in 
separating, identifying and determining the relative amounts of the components 
making up a sample of matter. It is mainly involved in the qualitative identification or 
detection of compounds and quantitative measurements of the substances present in 
bulk and pharmaceutical preparation. 
 
Analytical instrumentation plays an important role in the production and 
evaluation of new products and in the protection of consumers and the environment. 
This instrumentation provides the lower detection limits required to assure safe foods, 
drugs, water and air. 
 
TYPES 
 
There are mainly two types of chemical analysis:  
1. Qualitative (Identification)  
2. Quantitative (Estimation) 
 
1. Qualitative analysis is performed to establish composition of 
natural/synthetic substances. These tests are performed to indicate whether the 
substance or compound is present in the sample or not. Various qualitative 
tests are detection of evolved gas, formation of precipitates, limit tests, color 
change reactions, melting point and boiling point test etc. 
 
2. Quantitative analytical techniques are mainly used to quantify any 
compound or substance in the sample. These techniques are based on (a) the 
quantitative performance of suitable chemical reaction and either measuring 
the amount of reagent added to complete the reaction or measuring the amount 
of reaction product obtained. (b) The characteristic movement of a substance 
through a defined medium under controlled conditions. (c) Electrical 
measurement. (d) Measurement of some spectroscopic properties of the 
compound. 
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ROLE OF BIOANALYSIS IN PHARMACEUTICAL DRUG DEVELOPMENT (6) 
   Quantitative determination of drugs and their metabolites in biological fluids is 
termed as bioanalysis. This technique is used very early in the drug development 
process to provide support to drug discovery programs on the metabolic fate and 
pharmacokinetics of chemicals in living cells and in humans. 
 
   Bioanalytical methods play a major role in estimating the drugs, interferences, 
metabolites from various matrices such as pure drug, dosage form, intermediates and 
biological fluids. Drug assay technology is now sufficiently advanced for it to be 
possible to measure the plasma concentration of majority of drugs used in clinical 
practices. They are useful to measure plasma concentration of drugs to confirm 
adequate dosage, to identify signs of possible drug toxicity, the response of patients to 
drug therapy and drug interactions. 
 
   When a drug is administered orally it passes through the GIT and enters the 
systemic circulation undergoes metabolism, finally it is excreted as such or in the 
form of its metabolites. The studies on biological fluids is very challenging and time 
consuming , but these studies are necessary and utmost  important because biological 
fluids like blood, urine, cerebrospinal fluid and milk etc containing a relative quantity 
of drug and their metabolites can be known. Bio-analytical method which gives 
accurate and reproducible results has been increased significantly now a day. 
 
   Therapeutic efficacy of the particular drug can be known by bioanalysis. In 
Pharma field bioanalysis plays a significant role .Bioanalysis involves the following 
steps. 
 
 Selection and collection of biological fluid. 
 Preparation of sample –Analyte extraction from biological matrix. 
 Analyte detection done by various methods. 
 
   In bioanalytical drug analysis, common matrices are venous blood and 
plasma. Venous blood, with anticoagulant, is after centrifugation separated into 
plasma and blood cells. Centrifuged blood consists of 55% plasma and 45% blood 
cells. The plasma matrix is composed of some 90% water with remaining 10% being 
mostly plasma proteins. Sampling of biological matrix is the first step in the 
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analytical chain, and these samples must regularly be stored in a cooler or freezer 
before assay. When the samples have arrived at the laboratory, they need to be 
prepared for analysis. The aim is to improve the assay by removing interferences in 
the matrix, and often also concentrating the analyte. The need of sample preparation 
is determined by the complexity of the samples and by the application of the 
analytical method. 
 
   Detection of drug or its metabolite in biological media is usually complicated 
by the matrix. Because of this, various types of cleanup procedures involved i.e. 
solvent extraction and chromatography are employed to effectively separate drug 
components form endogenous biological materials. The sensitivity and selectivity of 
the assay method was limited by the efficiency of the clean up methodology (7). 
 
   If the blood is allowed to clot and is then centrifuged, about 30 to 50% of the 
original volume is collected as serum (upper level). Thus, plasma generally is 
preferred because of its greater yield from blood. Blood, serum or plasma samples can 
be utilized for bioanalytical studies and may require protein denaturation steps before 
further processes. 
 
   If plasma or serum is used for the analytical procedure, the fresh whole blood 
should be centrifuged immediately at 5000 rpm for approximately 5 to 10 min, and 
the supernatant should be transferred by means of a suitable device, such as pasture 
pipette, to a clean container of appropriate size of storage. 
 
DIFFERENT TERMINOLOGY USED IN BIOANALYTICAL DEPARTMENT 
Accuracy: The degree of closeness of the determined value to the nominal or known 
true value under prescribed conditions. This is sometimes termed trueness. 
 
Analyte: A specified chemical moiety being measured or which can be intact drug, 
biomolecule or its derivative, metabolite and/or degradation product in a biological 
matrix. 
 
Analytical run (or batch): A complete set of analytical and study samples with 
appropriate number of standards and QCs for their validation. Several runs (or 
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batches) may be completed in one day, or one run (or batch) may take several days to 
complete. 
 
Biological matrix: A discrete material of biological origin that can be sampled and 
processed in a reproducible manner. Examples are blood, serum, plasma, urine, feces, 
saliva, sputum and various discrete tissues. 
 
Calibration Standard: A biological matrix to which a known amount of analyte has 
been added or spiked. Calibration standards are used to construct calibration curves 
from which the concentrations of analytes in QCs and in unknown study samples are 
determined. 
 
Internal standard: Test compound(s) (e.g. structurally similar analog, stable labeled 
compound) added to both calibration standards and samples at known and constant 
concentration to facilitate quantification of the target analyte(s). 
 
Matrix effect: The direct or indirect alteration or interference in response due to the 
presence of unintended analytes (for analysis) or other interfering substances in the 
sample. 
 
Method: A comprehensive description of all procedures used in sample analysis 
 
Precision: The closeness of agreement (degree of scatter) between a series of 
measurements obtained from multiple sampling of the same homogenous sample 
under the prescribed conditions. 
 
Processed: The final extract (prior to instrumental analysis) of the sample that has 
been subjected to various manipulations (e.g., extraction, dilution, concentration). 
 
Recovery: The extraction efficiency of an analytical process, reported as a percentage 
of the known amount of an analyte carried through the sample extraction and 
processing steps of the method. 
 
Reproducibility: The precision between two laboratories. It also represents precision 
of the method under the same operating conditions over a short period of time. 
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Sample: A generic term encompassing controls, blanks, unknowns and processed 
samples as described below. 
 
Blank: A sample of a biological matrix to which no analytes have been added that is 
used to assess the specificity of the bioanalytical method. 
 
Quality control sample (QC): A spiked sample used to monitor the performance of a 
Bioanalytical method and to assess the integrity and validity of the results of the 
unknown samples analyzed in an individual batch. 
 
Unknown: A biological sample that is the subject of the analysis. 
 
Selectivity: The ability of the Bioanalytical method to measure and differentiate the 
analytes in the presence of the components that may be expected to be present. These 
could include metabolites, Impurities, degradants or matrix components. 
 
System suitability: Determination of instrument performance (e.g., sensitivity and 
chromatographic retention) by analysis of a reference standard prior to running the 
analytical batch. 
 
VALIDATION: 
Full validation: Establishment of all validation parameters to apply to sample 
analysis for the Bioanalytical method for each analyte. 
 
Partial validation: Modification of validated bioanalytical methods that do not 
necessarily call for full validation. 
 
Cross-validation: Comparison validation parameters of two bioanalytical methods. 
 
STORAGE REQUIREMENTS FOR BIOLOGICAL SAMPLES (8) 
   In order to avoid decomposition or other potential chemical changes in the 
drugs to be analyzed, biological samples should be frozen immediately upon 
collection and thawed before analysis. When drugs are susceptible to plasma esterase, 
the addition of esterase inhibitors, such as sodium fluoride was immediately added 
after collection helps to prevent decomposition. 
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   When collecting and storing biological samples, the analyte should be 
contaminated with storage vessels. For example, plastic –ware frequently contains 
high boiling liquid bis (2-ethylhexyl) phthalate; similarly, the plunger-plugs of 
vacutainers are known to contain tri-butoxyethyl phosphate, which can be interfering 
certain drug analysis. 
 
EXTRACTION PROCEDURE FOR BIOLOGICAL SAMPLE 
   Sample preparation is a technique used to clean up a sample before analysis 
and/or to concentrate a sample to improve its detection. When samples are biological 
fluids such as plasma, serum or urine, this technique is described as bioanalytical 
sample preparation. 
 
Objectives of Bio-analytical sample preparation:- 
1. Removal of unwanted matrix components (primarily protein) that would 
interfere with analyte determination. 
2. Concentration of analyte to meet the detection limits of the analytical 
instrument. 
3. Exchange of the solvent or solution in which the analyte resides so that it is 
compatible with mobile phase for injection into a Chromatographic system. 
4. Dilution to reduce solvent strength or avoid solvent incompatibility. 
5. Stabilization of analyte to avoid hydrolytic or enzymatic degradation. 
 
  Blood, serum and plasma contain approximately 10,000 different proteins with 
a total concentration of 6–8 g/dL, and urine contains 50–100 mg of protein/dL.  
Plasma also contains approximately 3 mg/mL of sodium, 0.2 mg/mL of potassium, 
15–38.5 mg/dL of urea, and many other organic and inorganic compounds. With 
such complex mixtures and the dynamic ranges of proteins, fatty acids, lipids and 
salts, it is clear that it is important to remove these components from the analysis, as 
these factors could confound the analysis and flood the detector with irrelevant ions.  
 
GENERAL TECHNIQUES FOR SAMPLE PREPARATION (9):- 
  Many different sample preparation techniques are available for choosing a 
method to perform bioanalytical sample preparation. These techniques vary in many 
regards, such as simplicity, time requirement (in terms of speed and hands-on analyst 
time), ease of   automation, extraction chemistry expertise, concentration factor and 
selectivity of the final extract. 
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Typical choices of sample preparation techniques useful in bioanalysis 
 Dilution followed by injection 
 Solid Phase extraction 
 Protein precipitation 
 Filtration 
 Liquid-liquid extraction 
 Restricted access media 
 
Solid phase extraction 
  Solid phase extraction (SPE) is one of the most common bio-analytical extraction 
methods in publication literature, a search of journal articles using the science direct 
search engine for the term “SPE” yielded 151,017 hits, with 4,657 hits for the year 
2010 alone.  SPE involves a solid-liquid phase separation of the analytes from the 
biological sample, by the selective transfer between a liquid and solid state (9).  The 
analyte is physically separated from the biological matrix by the differential 
interacting with a solid phase sorbent material. These sorbents, packed primarily into 
either disposable cartridges or discs, can be polar, non-polar or ionic depending on the 
experimental requirements.  
 
 
Fig 1: Typical solid phase extraction tube and Disk 
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Solid phase extraction is based on four distinct protocol steps as illustrated in Fig 2. 
 
Step 1: Sorbent Conditioning   
Prior to the addition of the sample conditioning and packing of the cartridge is done. 
In order to remove the impurities a conditioning strong solvent like methanol is 
passed through cartridge which allows sorbent to be solvated. 
 
Step 2: Sample Loading  
In a weak solvent the sample is dissolved and passed through the cartridge. Sample is 
applied with a syringe or pipette or pumped into cartridge .This weak solvent helps in 
retention of strong analyte. 
 
Step 3: Washing 
In order, to remove the interferences and impurities the cartridge is washed with water 
or buffer. 
 
Step 4: Analyte Elution  
Strong elution solvent is passed through the cartridge and it gives 100% collection of 
analyte from this method. 
           The availability of commercially available solid phase extraction material, 
cartridges or sorbents, has led to uniformity in analysis and makes method replication 
and transfer from one lab to another more straightforward. SPE is also frequently used 
in on-line extraction.   Automation of sample clean-up is advantageous as it 
decreases the high level of manual handling and error associated with manual 
extraction procedures. Though on-line SPE is faster and allows for increased 
through-put injections and offers high recoveries, extensive method development is 
required to optimize many experimental variables. 
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Fig 2: Schematic of solid phase extraction procedure 
 
SOLID PHASE EXTRACTION THEORY  
How Compounds Are Retained by the Sorbent  
1) Reversed Phase  
(polar liquid phase, nonpolar modified solid phase)  
Hydrophobic interactions  
 nonpolar-nonpolar interactions  
 van der Waals or dispersion forces  
2) Normal Phase  
(nonpolar liquid phase, polar modified solid phase)  
Hydrophilic interactions  
 hydrogen bonding  
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 pi-pi interactions  
 dipole-dipole interactions  
 dipole-induced dipole interactions  
3) Ion Exchange  
Electrostatic attraction of charged group on compound to a charged group on 
the   sorbent’s surface  
4) Adsorption  
(interactions of compounds with unmodified materials) Hydrophobic and 
hydrophilic interactions may apply Depends on which solid phase is used 
 
Reversed Phase SPE 
Reversed phase separations involve a polar (usually aqueous; see Table An on 
page 8) or moderately polar sample matrix (mobile phase) and a no polar stationary 
phase. The analyte of interests typically mid- to no polar. Several SPE materials, such 
as the alkyl- or aryl-bonded silicas (LC-18, ENVI-18, LC-8, ENVI-8, LC-4, and LC-
Ph) are in the reversed phase category. Here, the hydrophilic silanol groups at the 
surface of the raw silica packing (typically 60Å pore size, 40μm particle size) have 
been chemically modified with hydrophobic alkyl or aryl functional groups by 
reaction with the corresponding silanes. 
 
The Role of pH in solid phase extraction  
   Solutions used in SPE procedures have a very broad pH range. Silica-based 
packings, such as those used in HPLC columns, usually have a stable pH range of 2 to 
7.5. At pH levels above and below this range, the bonded phase can be hydrolyzed 
and cleaved off the silica surface, or the silica itself can dissolve. In SPE, however, 
the solutions usually are in contact with the sorbent for short periods of time. The fact 
that SPE cartridges are disposable, and are meant to be used only once, allows one to 
use any pH to optimize retention or elution of analytes. If stability of the SPE 
cartridge at an extreme pH is crucial, polymeric or carbon-based SPE materials such 
as ENVI-Chrom P or ENVI-Carb may be used. These materials are stable over the pH 
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range of 1-14.  
  For reversed phase SPE procedures on bonded silicas, if trapping the analyte in 
the tube is desired, the pH of the conditioning solution and sample (if mostly or 
entirely aqueous) should be adjusted for optimum analyte retention. If the compound 
of interest is acidic or basic you should, in most cases, use a pH at which the 
compound is not charged. Retention of neutral compounds (no acidic or basic 
functional groups) usually is not affected by pH. Conversely, you can use a pH at 
which the unwanted compounds in the sample are retained on the SPE packing, but 
the analyte of interest passes through unretained. Secondary hydrophilic and cation 
exchange interactions of the analyte can be used for retention at a proper pH. (For 
more detail, see Secondary Interactions).  
  For adsorption media (e.g. ENVI-Carb and ENVI-Chrom P) that are used under 
reversed phase conditions, a pH should be chosen to maximize retention of analytes 
on the sorbent as with reversed phase bonded silicas. Elution is usually done with an 
organic solvent, so pH is usually not a factor at this point. Surprisingly, phenols retain 
better on ENVI-Chrom P when applied in solutions at a neutral pH, where phenols 
can be charged, than at an acidic pH levels where they are neutral. This shows that 
adsorption media may have different selectivities than the bonded silicas for certain 
compounds, and that a range of pH levels of the sample and conditioning solutions 
should be investigated when using these materials. 
 
Table no 1: Commonly used solvents in solid phase extraction  
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Determination of solid phase extraction procedure by sample characteristics 
 
 
 
 Protein precipitation 
   Protein precipitation is based on the interaction between the precipitation 
reagent and protein groups. Soluble proteins generally have a hydrophobic core 
surrounded by a hydrophilic surface including ionic groups that are not involved in 
intra-molecular binding.  Organic solvents interfere with the intra-molecular 
hydrophobic interactions of proteins. (10) 
         The addition of a volume of solvent (frequently acetonitrile) to the serum 
causes the proteins of the serum to precipitate and leaves the analyte of interest in 
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the solvent, which can either be injected directly or dried down and 
reconstituted in a smaller volume to concentration before injection. While this is the 
fastest and simplest method for sample preparation, it is the most likely to cause ion 
suppression issues, especially in ESI, where the co-elution of endogenous compounds 
such as lipids, phospholipids and fatty acids affect the ESI droplet desolvation 
process. (11) 
 
Fig 3: Schematic diagram of Protein precipitation technique. 
 
Liquid-Liquid Extraction (12) 
  Liquid-liquid extraction (LLE) is the simplest form of the extraction and 
purification of analytes from liquid samples. The basic principle is the tendency of an 
analyte to prefer one solvent over another immiscible solvent. The often-quoted 
partitioning coefficient of a species is Log P. This is defined as the ratio of the 
concentration in octanol divided by the concentration in water. The Log-P values of a 
vast number of species have been calculated, and there are computer programs that 
will calculate Log P and Log D simply from the chemical structure of the species. The 
use of high-purity solvents can make this technique expensive, especially if large 
volumes are required and then there is the disposal of these solvents. Carrying out 
LLE requires the use of two immiscible liquids and soluble samples. It is very useful 
for separating analytes from interferences by partitioning the sample between these 
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two immiscible liquids or phases. Typically, with LLE one phase will be aqueous 
(often the denser or heavier phase) and the second phase is an organic solvent (usually 
the lighter phase). Hydrophilic compounds prefer the polar aqueous phase, whereas 
hydrophobic compounds will prefer the organic solvent. Analytes extracted into the 
organic phase are recovered relatively easily by evaporation of the solvent, whereas 
analytes extracted into the aqueous phase are often amenable to direct analysis by 
high-performance liquid chromatography (HPLC). Extraction efficiency can be 
improved by solvent selection, solvent volume, pH, and by using the salting-out 
effect.  
 
   
Fig 4: Schematic representation of Liquid – Liquid Extraction 
Positive –  
 Known and standard technique. 
 Relatively simple to do as a routine. 
 Trend to micro LLE. 
 Low LOD’s are possible. 
Negative – 
 Moderate selective (limited in solvent selections). 
 Examine and use pH / ionic strength / temperature to get a selective extraction 
process. 
 Multiple extractions needed to get the recovery. 
 Often evaporation steps needed. 
 Emulsions formed cause recovery loss. 
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 Difficult to automate, semi-automated steps. 
 As routine method labor intensive. 
Analytical methods for quantitative determination of drugs in biological fluids: 
There are different types of methods for quantitative determination of drugs in 
biological fluids. According to biological fluid and drug to be quantitated these 
methods are selected. They are: 
a) Methods based on immunoassay procedure 
 Radioimmunoassay (RIA). 
 Enzyme-multiplied immunoassay technique. 
 Enzyme-linked immunosorbent assay (ELISA). 
b) Microbiological methods. 
c) Capillary electrophoresis. 
d) Chromatographic methods. 
 Gas chromatography (GC). 
 High performance liquid chromatography (HPLC). 
 Liquid chromatography-mass spectroscopy (LC-MS). 
 Gas chromatography –mass spectroscopy (GC-MS). 
Chromatographic methods are mostly used and important for the estimation of drugs 
in biological samples. Chromatography derived from “chroma” means “color” and 
“graphein” means “to write”. Separation of required analyte from the compounds by 
using the mobile phase and stationary phase is known as chromatography. Advanced 
methods for separation of samples from biological fluids are HPLC and their 
hyphenated methods like LC-MS; GC-MS. 
 
Drugs estimation in biological samples by HPLC 
Most of the drugs in biological samples can be analyzed by High performance 
Liquid Chromatography method because of several advantages like accuracy, 
precision, rapidity, and specificity, ease of automation and elimination of tedious 
extraction methods and isolation procedure. Some of the advantages are: 
 Speed (analysis can be completed in 20 min or less) 
 Higher sensitivity (various detectors can be employed) 
 Good resolution (wide variety of stationary phase) 
 Re-usable column (expensive columns but can be used for many Samples) 
 Ideal for the substance of low volatility 
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 Sample recovery, handling and maintenance were easy 
 Instrumentation leads itself to automation and quantization  
 Precise and accurate, 
 Calculation are done by integrator and  
 Suitable for preparative liquid chromatography on a much larger scale. 
 The different models of separation are in HPLC. Normal phase mode, Reverse 
phase mode, reversed phase ion pair chromatography, ion exchange chromatography, 
affinity chromatography and size exclusion chromatography (gel permeation and gel 
filtration chromatography). 
HPLC is historically divided into two different sub classes based on the 
polarity of the mobile and stationary phases. 
1. Normal phase high performance liquid chromatography. 
2. Reverse phase high performance liquid chromatography. 
 
Normal phase high performance liquid chromatography: 
   Techniques in which the stationary phase is more polar than the mobile phase 
is call normal phase high performance liquid chromatography. 
 Stationary Phase –Polar nature 
e.g.: Sio2, Al2O3. 
 Mobile Phase – Non-polar nature 
e.g.: Heptane, hexane, cyclohexane, CHCL3, CH3OH 
Mechanism: 
 Polar compounds travels slower and eluted slowly due to higher affinity b/w 
solute and stationary phase. 
 No polar compound travels faster and eluted first due to lower affinity b/w solute 
and stationary phase. 
 This technique is not widely used in pharmaceutical separation. 
 
Reverse phase high performance liquid chromatography: 
Techniques in which the mobile phase is more polar than the stationary phase is called 
reverse phase high performance liquid chromatography. 
 Stationary phase – Non-polar nature. 
e.g.: n-octadecyl, n-octyl, ethyl, phenyl diol, hydrophobic polymers. 
 Mobile Phase – polar nature. 
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e.g.: Methanol or Acetonitrile/water or buffer sometimes with additives of THF or 
dioxane. 
Mechanism: 
 A polar compound travels faster and eluted first due to lesser affinity b/w solute 
and stationary phase. 
 Non polar compounds travel slower and eluted slowly due to higher affinity b/w 
solute and stationary phase.   
Principle:  
 The principle of separation is normal phase mode and reverse phase mode is 
adsorption. When mixtures of components are introduced in to a HPLC 
column, they travel according to their relative affinities towards the stationary 
phase. The component which has more affinity towards the adsorbent travels 
slower.  
 The component which has less affinity towards the stationary phase travels 
faster. Since no two components have the same affinity towards the stationary 
phase, the components are separated. 
 Most of the drugs in multicomponent dosage forms can be analyzed by HPLC 
method because of the several advantages like rapidity, specificity, accuracy, 
precision and ease of automation in this method. HPLC method eliminates 
tedious extraction and isolation procedures.  
 The various component of HPLC are pumps (solvent delivery system), mixing 
unit, gradient controller and solvent degasser, injector (manual or auto), guard 
column, analytical column, detector, recorder, and /or integrators. Recent models are 
equipped with computers and software for data acquisition and processing. 
 
 
 
 
 
 
 
 
 
Fig 5:  Components of HPLC 
RECORDER 
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The choice of the column should be made after a careful consideration of the 
mode of the chromatographic technique. Three types of column are available based 
upon types of packing and particle size, namely, rigid solid, hard gels, and porous and 
peculiar layer beds, the column of smaller particles (3-10µ) are always preferred 
because they offer high efficiency(number of theoretical plates /meter) and speed of 
analysis. 
 The different types of detection used in HPLC method based on ultraviolet 
(UV), fluorescence, refractive index, mass spectrophotometric detector or a diode 
array detector (DAD) Chemical derivatisation procedure for HPLC are performed in 
order to improve detectability, to improved selectivity (or specificity), to modify the 
chromatographic properties, and in some cases to provide favorable mass spectral 
fragmentation pattern for structural elucidation when a mass spectrometer is used 
either as an off or on line detector. 
 Approaches to HPLC derivatisation involve both pre and post column 
methodology. In pre column procedures, derivatisation occurs in vitro before injection 
of the sample. In post column procedure, the reaction occurs after column separation 
by adding reagent to the mobile phase and /or by utilizing thermal, UV, catalytic or 
other effects. Among the chemical reagent employed in precolumn procedure are 
dansyl chloride, NBD chloride, o-phthaldehyde, and fluorescamine for drugs 
containing amino group, danshydrazine, NBD-hydrazine, and phenyl hydrazine for 
keto groups and aldehydes and p-nitro benzoyl chlorides for hydroxyl groups. Almost 
all of these reagents provide highly fluorescent derivative (called fluorophors) of a 
drug or metabolites except for phenyl hydrazine and p-nitrobenzoyl chloride, which 
are used to create a strong absorbing chromophores for better detection of a 
compound in the UV or visible region. 
When a drug or metabolite is difficult to derivatise but possess reasonable 
Lewis acid or base properties, an ion pair reagent is added to the mobile phase to form 
an ion–pair with compound, thereby enhancing detection and chromatographic 
properties. Ion pair technique such as this can be approached with both pre and post–
column methodology. Both chromogenic and fluorescing counter ions can be 
employed depending on the sensitivity requirements of the assay. 
 Methods for analyzing drug in biological sample can be developed, provided 
one has knowledge about the nature of the sample, namely, its molecular weight, 
polarity, ionic character, and the solubility parameter. An exact recipe for HPLC 
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however cannot be provided because method development involves considerable trial 
and error procedure. The most difficult problem usually is where to start, what type of 
column is worth trying with what kind of mobile phase. In general one begins with 
reverse phase chromatography, when the compounds are hydrophilic in nature with 
many polar groups and are water soluble. 
 The organic phase concentration required for the mobile phase can be 
estimated by gradient elution method. For aqueous sample mixtures, the best way to 
start is with gradient reversed phase chromatography. Gradient can be started with 5-
10% organic phase in the mobile phase and the organic phase concentration 
(acetonitrile or methanol) can be increased up to 100% within 20-30 min. Separation 
can then be optimized by changing the initial mobile phase composition and slope of 
gradient according to the chromatogram obtained from preliminary run. The initial 
mobile phase composition can be estimated on the basis of where the compounds of 
interest were eluted, namely, at what mobile phase composition. 
 Elution of drug molecules can be altered by changing the polarity of mobile 
phase. The elution strength of mobile phase depends upon its polarity, the stronger the 
polarity, higher is the elution. Ionic sample (acidic or basic) can be separated; if they 
are present in un-dissociated form. Dissociation of ionic sample may be suppressed by 
proper selection of pH. 
 The pH of mobile phase has to be selected in such a way that the compounds 
are not ionized. If the retention time is too short, the decrease of mobile phase 
concentration in the mobile phase can be in steps of 5%. If the retention times are too 
long, an increased in 5% steps of the organic phase concentration is needed. 
 Whenever acidic or basic are to be separated it is strongly advisable to control 
mobile phase pH by adding a buffer, pH of the buffer be adjusted before adding 
organic phase. The buffer selected for a particular separation should be used to control 
pH over the range of ≈ pKa ± 1.0 the buffer should transit light at or below 220 nm so 
as to allow low UV detection. 
 Optimization can be started only after a reasonable chromatogram has been 
obtained. A reasonable chromatogram means that the entire compounds are detected 
by more or less symmetrical peaks on the chromatogram. By a slight change in mobile 
phase composition, the shifting of the peaks can be expected. From a few 
experimental measurements, the position of the peaks can be predicted within the 
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range of investigated changes. An optimizing chromatogram is the one in which all 
the peaks are symmetrical and are well separated in less run time.  
 The peak resolution can be increased by using a more efficient column 
(column with high theoretical plate number, N), which can be achieve by using a 
column of smaller particle size, or a longer column these factor, however will 
increased the analysis time. Flow rate does not influence the resolution, but it has a 
strong effect on the analysis time. 
 The parameter that are affected by the changes in chromatographic condition 
are, 
 Resolution (Rs) 
 Capacity factor(K’), 
 Selectivity (α), 
 Column efficiency (N) and  
 Peak asymmetry Factor (As). 
 
High-performance liquid chromatography [HPLC] is now one of the most powerful 
tools in analytical chemistry. It has the ability to separate, identify and quantitated the 
compounds that are present in any sample that can be dissolved in a liquid. Today, 
compounds in trace concentrations as low as parts per trillion (ppt) may easily be 
identified. HPLC can be and has been applied to just above any sample, such as 
pharmaceuticals, food, nutraceuticals, cosmetics, environmental matrices, forensic 
samples and industrial chemicals. 
 
Mobile phases used in HPLC 
 
  In HPLC a broad variety of mobile phases can be used. According to the mode of 
HPLC mobile phase can be selected like polar nature or non-polar. Mobile phase 
selection depends on many factors like purity, sample solubility, chemical inertness, 
detector compatibility and low viscosity. Mostly organic solvents like acetonitrile, 
methanol, ethanol, formic acid etc are used. Sometimes these solvents are mixed with 
water and also can be used. These mobile phases should be selected according to the 
properties of drug to be estimated in HPLC, so its selection should be done carefully. 
Based on the mobile phase only the drug elutes and chromatogram of that drug comes 
properly. 
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LISTS OF STEPS NEEDED BEFORE ANY RUN BY HPLC (14): 
 Filter the solvents with membranes with cut off 0.22-0.45m. 
 Precipitates and colloids can be distinguished by using clean and transparent 
reservoirs. 
 Make sure that the solvents will be easily mixed with the previous solvents in 
the same inlets. For example methanol or water should not be placed instead of 
hexane directly, or any organic solvent should not be placed directly instead of 
a buffer reservoir. 
 Degas the solvents and remove by cleansing all the tubing that leads to the 
pump. 
 Connect the column according to the flow direction indicated on it (do not 
connect directly to the detector). 
 At a low flow rate stream the appropriate the solvents through the column 
(0.1-0.5 ml/min) or reach the composition gradually using the appropriate 
gradient. 
 Wait for a stable baseline and select an appropriate wavelength in the detector. 
 Prepare the set of methods in the workstation: Instrument method for the 
control on the system, processing method for the data processing and the 
report method for the report of final results. 
 A blank run should be performed to test the system and verify that it is clean 
from interferences when the methods are ready. 
 
Minimum requirement for HPLC: (15)  
A).Temperature: 
  Room temperature is the first choice. Elevated temperatures are sometimes used 
to reduce column pressure are enhancing selectivity. Typically, temperatures in excess 
of 60oC are not used. 
B).Retention time mechanism: 
  In general, HPLC is a dynamic adsorption process. Analyte molecules, while 
moving through the porous packing bead, tend to interact with the surface adsorption 
sites.  Depending on the HPLC mode, the different types of the adsorption forces may 
be included in the retention process: 
 Hydrophobic (non-specific) interactions are the main ones in Reversed-Phase 
Separations. 
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 Dipole-dipole (polar) interactions are dominated in normal phase mode. 
 Ionic interactions are responsible for the retention in ion-exchange Chromatography. All 
these interactions are competitive. Analyte molecules are competing with the eluent 
molecules for the adsorption sites. So, the stronger analyte molecules interact with the 
surface and the weaker the eluent interaction, the longer analyte will be retained on 
the surface. 
Significance of drug analysis in body fluids:  
  Bioanalytical studies have many important applications in pharmacy field. They 
are mainly: 
 Bioequivalence studies. 
 Forensic and toxicological studies. 
 Drug –drug interaction and Bioavailability. 
 Therapeutic drug monitoring (TDM). 
 Adverse effect. 
 Over dose. 
 Drug abuse in sports. 
 Pharmacokinetic studies and In clinical trials. 
 
Quantitative Analysis by HPLC (16):- 
  Three methods are generally used for quantitative analysis in HPLC. They are the 
external standard method, the internal standard method and standard addition method  
 
 External standard method  
  The external standard method involves the use of single standard or up to three 
standard solutions. The peak area or the height of the sample and the standard used are 
compared directly or the slope of calibration curved based on standards that contain 
known concentration of the compound of interest. 
 
 Internal standard method  
  A widely used technique of quantitation involves the addition of an internal 
standard to compensate for various analytical errors. In this approach, a known 
compound of a fix concentration is added to the known amount of sample to give 
separate peak in the chromatograms, to compensate for the losses of the compound of 
interest during sample pretreatment steps. Any loss of the compound of interest will 
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be accompanied by the loss of an equivalent fraction of internal standard. The 
accuracy of this approach obviously depends on the structural equivalence of the 
compounds of interest and the internal standard.    
 
The requirement for an internal standard must 
 Give a completely resolved peak with no interferences   
 Elute close to the compound of interest 
 Behave equivalent to the compound of interest for analysis like pretreatment, 
derivative formation, etc. 
 Be added at a concentration that will produce a peak area or peak height ratio 
of about unity with the compound of interest. 
 Not be present in original sample 
 Be stable, unreactive with the sample components, column packing and the 
mobile phase and  
 Be commercially available in high purity 
 
  The internal standard should be added to the sample prior to sample preparation 
procedure and homogenized with it .Response factor is used to determine the 
concentration of a sample component in the original sample. The response factor (Rf) 
is the ratio of peak area of sample component (Ax) and the internal standard (AIS) 
obtained by injecting the sample quantity. 
 Standard addition method:  
                 In this method for the sample solution known amount of standard is added. 
By plotting calibration curve graphically the quantitative analysis is carried out. This 
method is used for sample which contains which contains very small quantity of 
element to be analyzed. In trace analysis also this method is used. By adding the 
standard to sample solution the peak area is increased and concentration of sample 
will be computed by interpretation. 
Validation:  
   Validation is a process of stabling documented evidence, where high degree of 
assurance can be provided, that a specific activity will consistently produce a desired 
result or product meeting its predetermined specifications and quality 
characteristics(17).  
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  Validation is very important for a method. This has to be compulsory done after 
the method development. In order, to prove that process is consistently doing    
1. What it is supposed to do.  
2. To determine the process variable and acceptable limits for those variables and 
to set up appropriate in- process control. 
3. To assure the quality and to see that product is prepared in the reasonable 
amount of time.  
 
  Although there are various stages in the development and validation of an 
analytical procedure, the validation of the analytical method can be envisaged to be to 
consist of two distinct phases: 
a) The pre-study phase which comes before the actual start of the study and 
involves the  validation of the method on biological matrix human plasma 
samples and spiked plasma samples. 
b) The study phase in which the validated bioanalytical method is applied to the 
actual analysis of the samples from bioavailability and bioequivalence studies 
mainly to confirm the stability, accuracy and precision. 
 
Bioanalytical method validation (BMV) (18) 
  For quantitative determination of drugs and their metabolites in the in biological 
matrix bioanalytical method validation (BMV) is done and this gives information 
about various things like pharmacokinetic, bioequivalence, bioavailability, toxicology 
studies. For regulatory filings these studies will support. It is necessary to emphasize 
well-characterized and fully validated analytical methods to produce reliable results 
that can be satisfactorily interpreted. For each analytical method has its own 
characteristics which may vary from analyte to analyte in these instances. So, specific 
validation criteria is essential, to be developed for each analyte.  Most of the 
procedures, principles, and requirements for quantitative bioanalytical method 
validation are common to all types of analytical methods. In bioanalytical method 
validation two phases are present. They are: 
1. The bioanalytical method development phase in which the assay is defined and 
validated. 
2. The application to actual analysis of samples from pharmacokinetic, 
bioavailability, bioequivalence, and drug interaction studies. 
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  In bioanalytical method validation (BMV) validation is done by three different 
levels/types of validation are done.  They are Full validation, Partial validation, Cross 
validation.  
 
Full validation: 
  It is done when developing bioanalytical method for first time for a new drug. 
Full validation is performed when an existing assay for quantification was added by 
metabolites. 
 
Partial validation:   
  These are modifications to bioanalytical methods for which Full validation is not 
necessary. Modifications done for bioanalytical methods such as, small changes like 
change in species with matrix (from rat plasma to mouse plasma),change in matrix 
with in a species (from human urine to human plasma) change in laboratories or 
analysts, instruments, change in sampling process procedures, change in analytical 
method like changing detector.  
 
Cross validation:  
  In this two bioanalytical methods are compared. The “reference” method which is 
original one is compared with the revised one “comparator”. This is done where two 
bioanalytical methods are compared and from that same data is prepared for study. 
This is done in two ways. Spiked matrix samples and subjected samples validation 
done at sane site or done at different sites i.e. different laboratories or by using 
different techniques in same laboratory. 
 
FDA guidance on bioanalytical method validation (19):   
  For bioanalytical method validation FDA had given some guidelines. These 
guidelines are given the validation performed was to be accurate. They are: 
 
 Analyte stability in biological matrix at intended storage and operating 
conditions should be kept. 
 Standard curve for matrix-based one should contain minimum 5 standards 
without including blank and it should cover the entire range of concentrations 
expected. 
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 Essential parameters that are performed for acceptability of bioanalytical 
method are precision, accuracy, selectivity, sensitivity and reproducibility. 
 For lowest concentration on the standard curve the lower limit of 
quantification can be used and that is not confused with limit of detection. 
 During the Full validation of a bioanalytical method the below parameters 
should be defined. 
 
Validation parameters (20):  
Different Types of Validation characteristics: 
 Precision 
 Repeatability   
 Intermediate Precision  
 Reproducibility 
 Accuracy 
 Specificity  Selectivity 
 Linearity  Range 
 Limit of Detection (LOD) 
 Lower Limit of Quantification (LLOQ) 
 Robustness 
 Ruggedness. 
 System Suitability 
1) Precision:  
   When the procedure is applied repeatedly to multiple samplings of single 
homogenous sample under prescribed conditions then precision, is a closeness of 
individual measurements of the analyte. It is done at three levels such as repeatability, 
intermediate precision, and reproducibility. 
 
Repeatability: It expresses precision under same operating conditions i.e. with in the 
laboratory same analyst using same equipment over a short period of time. 
 
Intermediate precision: It is the precision under different laboratory conditions i.e. 
varying only in different analyst, on different days, or using different equipments 
within the same laboratory. 
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Reproducibility: It is the precision between different laboratories and is often 
determined in method transfer experiments  
 
Acceptance Criteria: 
 Percentage Relative  deviation (%RSD)  NMT 1 % (Instrument precision) 
 (%RSD)  NMT -2% (Intra- assay precision) 
 
2) Accuracy:  
   It is the closeness of mean tests results obtained by the method to true 
concentration of analyte. It is also named as trueness. Accuracy is determined by 
replicate analysis of samples containing known amounts of the analyte.  Most 
commonly used method for determination of accuracy is recovery studies. The usual 
range is being 10% above or below the expected range of claim. The % recovery was 
calculated using the formula, 
 
                                     100
)(
covRe%
bX
aba
ery

  
 Where, 
 a – Amount of drug present in sample 
 b – Amount of standard added to the sample 
 
Acceptance Criteria: 
 
 In assay method, mean recovery will be 100% ± 2% at each concentration between 
the ranges of 80-120% of the target concentration. 
 In impurity method, mean recovery will be 0.1% absolute of the theoretical 
concentration or 10% relative, whichever is greater for impurities between the ranges 
of 0.1-2.5 % (V/W). 
 
3) Limit of detection (LOD): 
    The limit of detection is the lowest concentration of analyte in the sample 
which can be detected but not quantified under given experimental conditions. The 
lowest concentration which can be distinguished from the background noise with a 
certain degree of confidence is defined as limit of detection. Prepare the blank 
solution as per test method and inject six times into the chromatographic system. 
Similarly prepare the linearity solution staring from lowest possible concentration of 
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analyte to 150 % (or as per protocol) of target concentration and establish the linearity 
curve. 
   The detection limit (DL) may be expressed as: 
 
                 LOD = 3.3 X Standard deviation of the response of the blank (σ)                                                                                                                                                                                                
Slope  
  The slope shall be estimated from the calibration curve of the analyte. 
4) Lower Limit of quantification (LLOQ): 
   It is also the lowest concentration of analyte in the sample but quantitatively 
determined with suitable accuracy and precision. 
In calibration curve it is the lowest concentration point. It is determined by accuracy 
by the presence of background signal and by precision i.e. reproducibility of analyte 
in the method. 
 
 
  LOD = 10 X Standard deviation of the response of the blank (σ)                                                                                                                                                                   
     Slope  
 
 Acceptance Criteria: 
 In Pharmaceutical application, the LOQ is typically set at minimum 0.05% for    
active pharmaceutical ingredients. 
 LOQ defined as the lowest concentration providing a RSD of 5%. 
 LOQ should be at least 10% of the minimum effective concentration for 
clinical applications. 
 
5) Specificity: 
   A method is said to be specific when it produces proper response only for a 
single analyte. It can be demonstrated by performing Placebo / blank interference and 
forced degradation studies. If the expected impurities or related substances are 
available, then they should be analyzed along with the analyte or sample to check the 
system suitability, retention factor, tailing factor and resolution etc. In this peak purity 
studies are done for specificity.  
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6) Linearity:  
  As per ICH definition “the ability to obtain test results which are directly 
proportional to the concentration of an analyte within given range is known as 
linearity of an analytical procedure”. By using correlation coefficient this can be 
tested. Using correlation coefficient is a benefit as it is a relationship between 
concentration and response data. In this data is analyzed by linear least square 
regression co-efficient and b of the linear equation,                                   
Y= aX + b 
By the above equation regression r value can be known. For the method to be linear 
the r value should be close to1. Where Y is the measured output signal, X is the 
concentration of sample, a is the slope, b is the intercept. 
Acceptance criteria: 
   Coefficient of correlation should be NLT 0.99. 
 
7) Robustness:  
  It is the measure of its capacity to remain unaffected by small, but deliberate 
variations in method parameters and provides an indication of its reliability during 
normal usage. 
 
8) Ruggedness:  
   Ruggedness according to the USP is “the degree of reproducibility of test results 
obtained by the analysis of the same samples under a variety of normal test 
conditions, such as different labs, different analysts, and different lots of reagents. The 
following are the typical method parameters need to test during method validation:  
 
 Analyst-to-Analyst variability. 
 Column-to-Column variability. 
 On different days. 
 In different laboratories. 
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APPLICATION OF A VALIDATED BIOANALYTICAL METHOD TO 
ROUTINE DRUG ANALYSIS (21) 
   Many of the above principles under method establishment and validation are 
relevant to within study validation. This section will emphasize the validation 
parameters that should be evaluated during routine application of a validated 
bioanalytical method to a particular study. Following a successful validation which 
meets an a prior set acceptance criteria for accuracy and precision, examination of 
biological samples can be done by single determination without a need for duplicate 
or replicate analysis. The need for duplicate analysis may arise for special cases. For 
example, in the case of a difficult procedure for labile analyte (s), when the precision 
and accuracy tolerances are difficult to achieve, duplicates analyses may be essential.  
       A matrix-based standard curve should be generated for each analytical batch for 
each analyte and should be used in calculating the concentration of analyte in the 
unknown samples assayed with that run. It is important to use a matrix based standard 
curve that will cover the entire range of concentrations in the unknown samples. 
Estimation of unknowns by extrapolations of standard curve below the LLOQ or 
above the ULOQ is not recommended. Instead, it is recommended that the standard 
curve be re-determined or samples be reassayed after dilution with the matrix. 
 A matrix-based standard curve should consist of a minimum of five to eight 
standard points, excluding blanks (either single or replicate), covering the entire 
range. 
 Response Function: Typically, the same curve fitting, weighting and goodness of 
fit determined during pre-study validation should be utilized for the standard 
curve within study. Response function is determined by appropriate statistical 
tests based on the actual standard points during each run in the validation.  
 The QC samples should be used to accept or reject the run. These QC samples are 
matrix spiked with analyte. 
 System suitability: Based on the analyte and technique, a specific standard 
operating procedure (or sample) can be identified to assure the optimum 
operation of the system employed. 
 Any required sample dilutions must utilize like matrix (e.g. human to human) 
obviating the need to incorporate actual within-study dilution matrix QC samples. 
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Table No 2: Method Validation Requirements for Example (ICH) 
METHOD VALIDATION 
REQUIREMENTS 
ACCEPTANCE 
CRITERIA 
Precision 
Assay repeatability 
Intermediate precision (Ruggedness) 
 
                  ≤ 1% RSD 
      ≤ 2% RSD 
Accuracy 
Mean recovery per concentration 
 
       100.0% ± 2.0% 
Limit of detection 
        Signal to-to-noise ratio 
 
                       ≥ 3:1 
Limit of quantification   
        Signal to-to-noise ratio 
 
       ≥ 10:1 
Linearity/Range 
        Correlation coefficient 
        y-Intercept 
        Visual 
 
                    >0.99 
         ± 10% 
                     Linear 
Robustness 
        System suitability met 
        Solution stability 
 
         yes 
± 2% change from time zero 
Specificity 
      Resolution from main peak 
 
>2 min. (retention time) 
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2. LITERATURE REVIEW 
1) R.Rajameena etal22 Developed and Validated for the estimation of Clindamycin 
phosphate and Clotrimazole in pharmaceutical dosage forms using Reverse Phase High 
Performance Liquid Chromatographic Method. The elution was done using a Hypersil 
BDS C8 (250 × 4.6 mm; 5µm) column using mobile phase consisting of Phosphate buffer 
pH 2.5 and Acetonitrile in the ratio of 70:30 was used. The detection wavelength was 210 
nm and the flow rate was 1.0 ml/min. The linearity was found in the range of 80-120 
mg/ml. The method was successfully applied to the pharmaceutical formulation because 
no chromatographic interferences from peccaries excipients were found. 
 
2) Amit V Patel etal23 Developed and Validated reversed‑ phase HPLC method for 
simultaneous estimation of Clotrimazole and Beclomethasone dipropionate in lotion and 
cream dosage form. In this method, the chromatographic separation was achieved on a 
Kromasil C18 (150 mm × 4.6 mm, 5 μm) analytical column. A mixture of acetonitrile–
water (70:30, v/v) was used as the mobile phase, at a flow rate of 1 ml/min and detector 
wavelength at 254 nm. The retention time of CT and BD was found to be 5.4 and 4 min, 
respectively. The linear dynamic ranges were from 2-16 μg/ml and 80-640 μg/ml for BD 
and CT, respectively. The developed method was validated and found to be simple, 
specific, accurate and precise and can be used for routine quality control analysis of titled 
drugs in combination in lotion and cream formulation. 
 
3) Silveira etal24 Developed and Validated a simple Reverse phase- HPLC Method for the 
assay of Clotrimazole loaded nanocapsule suspensions.  The chromatographic conditions 
were RP Phenomenex column (250 x 4.60 mm, 5 µm particle size) using mobile phase 
methanol-water (90:10) at isocratic flow rate of 1mL/min, injection volume at 20 µL and 
the detection was performed at 229 nm.  The proposed method is specific, precise, 
accurate, linear for the concentration range of 2.0-10.0 mg/mL and robust. 
 
4) Renata Hajkova etal25 Developed and Validated HPLC method for determination of 
Clotrimazole and its two degradation products in spray formulation. In this method, the 
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determination of three compounds in spray solution (active component Clotrimazole and 
two degradation products imidazole and (2-chlorophenyl)diphenylmethanol) using 
ibuprofen as an internal standard was developed and validated. Reversed-phase 
chromatography was performed on Zorbax® SB-Phenyl column (75 mm × 4.6 mm, 3.5 
µm) using mobile phase for separation of clotrimazole, degradation products imidazole 
and (2-chlorophenyl)diphenylmethanol and ibuprofen as internal standard consists of a 
mixture of acetonitrile and water (65:35, v/v) with pH conditioned by phosphoric acid to 
3.5. At a flow rate of 0.5 ml min−1 and detection at 210 nm, the total time of analysis was 
less than 6 min. 
 
5) Dr. Adnan Manassra etal26 reported HPLC method for Simultaneous estimation of 
Betamethasone and Clotrimazole in Cream Formulations. The elution was done using a 
mobile phase consisting of methanol-acetate buffer pH 6.8 -acetonitrile (33:27:40, v/v) 
on C18 (250 X 4.0 mm) stationary phase and spectrophotometric UV detection at 254 
nm. The linearity range was found 0.025 to 0.075 mg/ml for betamethasone and 
Clotrimazole. 
 
6) FrankWienen etal27 reported a capillary electrophoretic method for estimation of               
Clotrimazole in mice plasma. Sample preparation was carried out by protein precipitation 
using methanol. Quantification of Clotrimazole was achieved by means of capillary 
electrophoresis using Ketoconazole as an internal standard (IS). The background 
electrolyte (BGE) composed of a Tris buffer solution (100 mM, pH 3.0, adjusted with 
acetic acid) and methanol (8:2, v/v). Injection was carried out electro kinetically with 10 
kV over a time period of 20s. A special rinsing procedure utilizing a sequence of a 
SDS/methanol solution, a sodium hydroxide solution, water and BGE, was applied to 
enhance the reproducibility. With this procedure, an intermediate precision (day-to-day 
precision) of the area ratios of Clotrimazole and IS of 5.0% for 0.5 mg/ml-1 and 2.6% for 
10 mg/ml-1 was obtained.  
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3. DRUG PROFILE(28) 
CLOTRIMAZOLE 
3.1 Chemical profile [28] 
Brand name: 
           Candid, Abzorb, Canazole, Clocit VG, Mycelex, Moncid, Oraloz  
Chemical name/IUPAC NAME: 
           1-[(2-chlorophenyl) (diphenyl)methyl]-1H-imidazole  
Molecular formula: 
           C22H17ClN2 
Mol. mass: 344.837 g/mol 
Structure: 
              Fig 1: MOLECULAR STRUCTURE OF CLOTRIMAZOLE 
                                        
 
Pharmacokinetic data: 
        Bioavailability : 10.9 ± 6.8% (oral)         
Metabolism  : Hepatic (metabolized to inactive metabolites) 
        Protein Binding     : 90% 
        Half-life  : 2 hrs 
        Excretion  : Not available 
        Routes        : Topical, Oral 
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Description: 
Clotrimazole is an odorless, white crystalline substance. It is practically insoluble 
in water, sparingly soluble in ether and very soluble in polyene glycol 400, ethanol and 
chloroform. 
 
Category [28]: 
Antifungal and Inhibitor of Cytochrome P450 Oxidase 
 
Dose [28]: 
Each mL of Clotrimazole topical solution contains 10 mg Clotrimazole, USP in a 
nonaqueous vehicle of polyethylene glycol 400. 
Indication: 
For the local treatment of Mouth ulcer, oropharyngeal candidiasis and vaginal 
yeast infections, also used in fungal infections of the skin such as ringworm, athlete's 
foot, and jock itch. 
 
5.2 Pharmacological profile  
Mechanism of action: 
Clotrimazole interacts with yeast 14-α demethylase, a cytochrome P-450 enzyme 
that converts lanosterol to ergosterol, an essential component of the membrane. In this 
way, clotrimazole inhibits ergosterol synthesis, resulting in increased cellular 
permeability. Clotrimazole may also inhibit endogenous respiration, interact with 
membrane phospholipids, inhibit the transformation of yeasts to mycelial forms and the 
uptake of purine, impair triglyceride and/or phospholipid biosynthesis, and inhibit the 
movement of calcium and potassium ions across the cell membrane by blocking the ion 
transport pathway known as the Gardos channel. 
 
Pharmacodynamics  
Clotrimazole action leads to increased membrane permeability and apparent 
disruption of enzyme systems bound to the membrane. In pharmaceutical formulation, 
Betamethasone and Clotrimazole are used together to treat cutaneous tinea infections. In 
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studies of fungal cultures, the minimum fungicidal concentration of clotrimazole caused 
leakage of intracellular phosphorous compounds into the ambient medium with 
concomitant breakdown of cellular nucleic acids, and accelerated potassium etflux. Both 
of these events began rapidly and extensively after addition of the drug to the cultures. 
The primary action of clotrimazole is against dividing and growing organisms. 
Drug Interactions: 
The limited therapeutic arsenal and the increase in reports of fungal resistance to 
multiple antifungal agents have made fungal infections a major therapeutic challenge. 
Clotrimazole Antagonises with polyene antibiotics. The polyene antibiotics like 
Natamycin inhibits growth of yeasts and fungi via the immediate inhibition of amino acid 
and glucose transport across the plasma membrane. This is attributable to ergosterol-
specific and reversible inhibition of membrane transport proteins. Therefore polyene 
antibiotics interferes with Clotrimazole administration.  
 
Adverse reactions: 
The following adverse reactions have been reported in connection with the use of 
Clotrimazole and symptoms of overdose include erythema, stinging, blistering, peeling, 
edema, pruritus, urticaria, burning, and general irritation of the skin, and cramps. 
 
Contraindications: 
 
It is not known whether this drug is excreted in human milk. Because many drugs 
are excreted in human milk, caution should be exercised when Clotrimazole is used by a 
nursing woman. 
 
Safety and effectiveness in pediatric patients have been established for 
Clotrimazole when used as indicated and in the recommended dosage. 
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4. AIM AND OBJECTIVE 
 
 
Estimation of drugs in biological media is increasingly important nowadays, which 
reveals information like bioavailability, bioequivalence, drug abuse, and pharmacokinetics and 
drug research. 
HPLC is the most suitable technique for the analysis of biological fluids owing to its 
well-developed characteristics and ruggedness. It is an extremely sensitive, precise, accurate, and 
rapid, separation technique. 
Clotrimazole is a broad spectrum antifungal agent that is used for the treatment of 
infections caused by various species of pathogenic dermatophytes, yeasts, and Malassezia furfur. 
The primary action of Clotrimazole is against dividing and growing organisms. Clotrimazole 
interacts with yeast 14-α demethylase, a cytochrome P-450 enzyme that converts lanosterol to 
ergosterol, an essential component of the membrane. In this way, Clotrimazole inhibits 
ergosterol synthesis, resulting in increased cellular permeability.  
Few analytical methods were reported for the quantitative determination of Clotrimazole 
and  its combination with other drugs  by HPLC. Only one method was reported for Clotrimazole 
in mice plasma by capillary electrophoresis. But there is no RP-HPLC method reported for the 
bio-analytical method development in human plasma using protein precipitation method under 
different chromatographic conditions. 
The present study is planned to develop newer analytical method for the determination of 
Clotrimazole by bio-analytical method development in human plasma using protein precipitation 
by RP-HPLC under different chromatographic conditions. 
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The reasons for determination of Clotrimazole Bio-Analytical method by RP-HPLC are 
as follows:  
 To develop new RP-HPLC Method by Isocratic mode. 
 To reduce the run time. 
 To carry out estimation of Clotrimazole by using different chromatographic conditions. 
 To develop a new procedure for protein precipitation method. 
    Advantages of less run time in HPLC: 
 It’s beneficial to the company economically. 
 To estimate the different compounds with less time in different formulations like tablets, 
capsules, syrups, expectorants and injections.  
 Utilisation of minimum solvent. 
 Reduce the cost. 
 Less utilisation of men, machine and materials. 
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5. PLAN OF WORK 
 
HIGH PERFORMANCE LIQUID CHROMATOGRAPHIC METHOD: 
 
Bioanalytical method development for Clotrimazole: 
            The present work is planned  to divide into three phases: 
 
 PHASE I 
          1. Optimization of chromatographic conditions  
 Selection of wavelength  
 Selection of initial separation conditions   
 Selection of mobile phase (pH, peak modifier, solvent strength, ratio and flow 
rate) 
 Nature of the stationary phase 
 Selection of internal standard 
 Sample preparation by protein precipitation method 
 Estimation of clotrimazole 
 
  PHASE II 
           2. Validation of the method 
        The developed method were proposed to be validated using the various validation   
        parameters such as,  
 Accuracy 
 Precision 
 Limit of detection (LOD)  
 Lower Limit of quantitation (LLOQ) 
 Selectivity / Specificity 
 System suitability 
 Ruggedness  
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HIGH PERFORMANCE LIQUID CHROMATOGRAPHY 
Materials and Instruments used 
Drug sample and Study products 
Clotrimazole was obtained from Hetero Healthcare Ltd, Hyderabad, India.  
Ibuprofen was obtained from Hetero Healthcare Ltd, Hyderabad, India. 
Plasma  
Blank plasma was collected from Kovai Medical Center and Hospitals, Coimbatore. 
 
Chemicals and solvents used for estimation- 
HPLC Water     - Qualigens, Mumbai, India. 
Acetonitrile                   -    Himedia, Mumbai, India. 
Methanol         -  Himedia, Mumbai, India. 
Distilled water                   -  Double Distilled water.  
Potassium Di-hydrogen phosphate  -      Analytical grade, SD fine chemicals,  
                                 Mumbai.  
Orthophosphoric acid   -      SD fine chem. Ltd, Mumbai. 
Triethylamine    -      Analytical grade, SD fine chemicals 
Instruments used: 
 Elico pH meter LI 127. 
 Shimadzu LC-20 AT HPLC. 
 SPD-M20A Prominence diode array detector. 
 Shimadzu 1700 LC-UV Spectrophotometer. 
 Sonica ultrasonic cleaner.  
 Solvent filtration unit – Millipore. 
 Shimadzu electronic balance AY 220. 
 Ultra cooling centrifuge – Remi, India 
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OPTIMIZATION OF CHROMATOGRAPHIC CONDITION FOR THE 
ESTIMATION OF CLOTRIMAZOLE (37) 
 Selection of Wavelength- 
 An uv spectrum of 100 µg/ml Clotrimazole in methanol was recorded by scanning 
in the range of 200 nm to 400 nm. A wavelength which gives good response for the drugs 
to be detected is to be selected. From the UV spectrum a wavelength of 215 nm was 
selected. Clotrimazole showed maximum absorbance at this wavelength.  
 
Selection of Chromatographic Method 
 Selection of proper chromatographic method depends on the nature of the sample 
or its properties like ionic/ionizable/neutral character, its molecular weight and solubility. 
The drug selected for the present study was polar in nature hence, reverse phase HPLC or 
ion-pair or ion–exchange chromatography method must be used. Because of its simplicity 
and suitability for initial separations reverse phase method was selected. 
 
Initial chromatographic conditions for separation of Clotrimazole  
Standard solution:   
                 100μg/ml of Clotrimazole was prepared by dissolving in 10 ml of HPLC grade 
Clotrimazole. 
 
 Equipment 
          System       : Shimadzu gradient HPLC 
            Pump          : LC-20AT prominence solvent delivery system 
            Detector     : SPD-M20A prominence diode array detector 
            Injector      : Rheodyne 7725i with 20µl loop 
 
 
 
 Methodology 
 
Dept. of Analysis, KMCH College of Pharmacy Page 42 
 
 
 
 
Chromatographic conditions – 1 
Stationary phase  : Phenomenex C18 column  
Solvent Phase     : Solvent A-Water 
                                                 Solvent B-Methanol  
Solvent Ratio     : 50:50 
Detection wavelength  : 215 nm 
Flow rate   : 1 ml/min 
Injection volume          :           20µL     
Column Temperature  : Ambient 
 
 
Fig 8 - Chromatographic conditions – 1 
 
 At the above chromatographic conditions Clotrimazole was eluted at the retention 
time of 9.8 min. The peak observed was fronting and splitting, thus not selected further for 
studies. 
 
 
 Methodology 
 
Dept. of Analysis, KMCH College of Pharmacy Page 43 
 
 
 
Chromatographic conditions – 2 
Stationary phase  : Phenomenex C18 column 
Solvent Phase     : Solvent A-Water    
                                                 Solvent B-Acetonitrile   
Solvent Ratio     : 60:40  
Detection wave length :  215 nm 
Flow rate   : 1 ml/min 
Injection volume          :           20µL 
Column Temperature   : Ambient 
 
Fig 9 - Chromatographic conditions – 2 
 
 Clotrimazole was eluted at retention time of 6.2 minute with peak splitting and 
tailing, hence not selected further for method development. 
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Chromatographic conditions – 3 
Stationary phase  : Phenomenex C18 column 
Solvent Phase     : Solvent A-0.5% TEA in water pH adjusted to 5.5 (with      
                                                 Orthophosphoric Acid) 
                                                 Solvent B-Acetonitrile  
Solvent Ratio     : 30:70  
Detection wave length :  215 nm 
Flow rate   : 1 ml/min 
Injection volume          :           20µL 
Column Temperature  :  Ambient 
 
 
 
Fig 10 - Chromatographic conditions – 3 
 
  Clotrimazole was eluted at retention time 5.5 minutes with peak fronting and peak 
tailing,   hence not selected further for method development. 
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Chromatographic conditions – 4 
 
Stationary phase  :          Phenomenex C18 column 
Solvent Phase               :          Solvent A-0.5% Triethylamine in Water pH adjusted to 4.5  
              (with Orthophosphoric Acid) Solvent B-Acetonitrile   
Solvent Ratio     : 40:60  
Detection wave length :  215 nm 
Flow rate   : 1 ml/min 
Injection volume          :           20µL 
Column Temperature  :  Ambient 
 
 
Fig 11 - Chromatographic conditions – 4 
 
 Clotrimazole was eluted at retention time of 11.3 minutes with peak tailing, and 
hence, not selected further for method development. 
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Chromatographic conditions – 5 
 
Stationary phase : Phenomenex C18 column 
Solvent Phase             :            Solvent A-0.5% Triethylamine inWater pH adjusted to 3.5 
                                                (With Orthophosphoric Acid) 
                                                Solvent B-Acetonitrile   
Solvent Ratio    : 35:65 
Detection wave length:  215 nm 
Flow rate  : 1 ml/min 
Injection volume         :           20µL 
Column Temperature :  Ambient 
 
 
Fig 12 - Chromatographic conditions – 5 
 
 Clotrimazole was eluted at retention time of 7.0 minutes and 4.5 for IS with peak 
fronting, and tailing hence not selected further for method development.  
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 Fixed Chromatographic Conditions – 6 
 
Stationary phase : Phenomenex C18 column 
Solvent Phase   : Solvent A-0.5% Triethylamine in Water pH adjusted to 3.0 (with 
Orthophosphoric Acid)  Solvent B-Acetonitrile 
Solvent Ratio    : 20:80 
Detection wave length:  215 nm 
Flow rate  : 1 ml/min 
Injection volume         :           20µL 
Column Temperature :  Ambient 
 
 
Fig 13 - Chromatographic conditions – 6 
 Clotrimazole was eluted at 8.3 mins and internal standard ibuprofen at 5.2 with 
perfect peak properties, hence selected for further studies.   
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Preparation of standard solution of clotrimazole: 
Ten mg of standard Clotrimazole was weighed and dissolved in mobile phase and 
made upto 10 ml in a volumetric flask. It was further diluted with mobile phase to obtain 
the concentration in the range of 10-50 g/ml. 
 
Effect of pH 
Table 1. Effect of pH on development of chromatogram 
 
 
 
 
 
 
 
Effect of ratio of mobile phase 
The mobile phase (0.5% Triethylamine in water adjusted to 3 and acetonitrile) in the ratio 
of 40:60, 30:70, 20:80 was tried and the chromatogram was recorded at 215 nm with a flow rate 
of 1ml/min. At 20:80 ratios symmetric peaks were eluted at 5.3 and 8.3 for internal standard and 
Clotrimazole respectively. At 40:60 and 30:70 peaks were asymmetrical in shape. Thus for the 
present study 20:80 ratio of (0.5% Triethylamine in water) and acetonitrile was selected as the 
mobile phase. 
Effect of flow rate  
 Keeping the mobile phase ratio at 20:20, v/v 0.5% Triethylamine in water: acetonitrile, 
the chromatograms were recorded at a flow rate of 0.5ml/min, 1.0ml/min 1.5ml/min. At flow rate 
Drug Ph Retention time 
(min) 
Observation 
 
Clotrimazole 
 
5.5 
4.5 
3.5 
3.0 
5.5 
11.3 
7.0  
8.3  
Fronting & Tailing  
Tailing 
Tailing  
 
Good 
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of`1.0ml/min, the peaks were sharp and separated with good resolution. Hence, 1ml/min was 
kept constant for the present analysis. 
Selection of internal standard 
 Based upon polarity and solubility, Albendazole, Neproxin, and Ibuprofen were 
selected and chromatographed along with the standard drug. The elution time of Ibuprofen 
was 5 min. The peak of ibuprofen was symmetric and well resolved from the peak of the 
Clotrimazole. Hence, for the present study ibuprofen was selected as the internal standard. 
 
Pretreatment method for biological fluid: 
 Method of sample preparation is an important criterion for biological samples. For the 
present study plasma was obtained from clinical laboratory services of KMCH hospital, 
coimbatore. Protein precipitation method was selected for the present study.  
 
 
Protein precipitation 
This method is the most commonly used method for the extraction of analytes from 
biological fluids. In this method precipitating agents like acetonitrile, methanol and mixture of 
acetonitrile-methanol etc was added to the blank plasma to precipitate the proteins present in the 
plasma and then the precipitate formed was removed by filtration or centrifugation. The 
supernatant resulted is directly injected into HPLC column without any further treatment and 
chromatograms were recorded. 
An aliquot of 0.1ml of plasma in a glass tube 0.05 ml of standard solution, 0.1 ml of 
internal standard solution and 0.25 ml of mixture of acetonitrile-methanol in the ratio of 
(80:20,v/v) was added and then centrifuged for 15 minutes at 5000 rpm. The same extraction 
procedure was also repeated by using methanol and acetonitrile separately for extraction of drug 
from plasma and the percentage recovery was calculated for all the precipitating agents.  
The chromatograms of plasma extracted with acetonitrile, methanol and mixture of 
acetonitrile- methanol (80:20, v/v) were recorded using the fixed chromatographic conditions. 
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The chromatogram of blank plasma without any drug was also recorded. Based up on the 
percentage recovery acetonitrile-methanol mixture (80:20, v/v) was selected for the present study 
because of its higher percentage recovery.  
Preparation of standard stock solution: 
  Stock solution of Clotrimazole and internal standard 1mg/ml were prepared 
separately by dissolving 10mg of each drug in 10ml standard flasks and the volume was made 
up to 10 ml with the mobile phase.  
 
Working standards: 
 From the stock solution working standard solutions of 100µg/ml was prepared by 
diluting 1ml to 10ml with mobile phase. Further solutions were made by from the above 
solution by diluting 0.1ml, 0.2ml, 0.3ml, 0.4ml, and 0.5ml standard solutions to 10ml in a 
standard flask with mobile phase to get effect concentrations of 1, 2, 3, 4, and 5µg/ml 
respectively. In the similar way the working standards were prepared for internal standard 
also. 
 
Preparation of standard graph: 
Preparation of calibration standards 
 To 0.1 ml of blank plasma, 0.05 ml of working standard solution of Clotrimazole and 0.1 
ml of internal standard working solutions were added to get concentration of 50, 100, 150, 200 
and 250ng/ml respectively. To these calibration standards 0.25 ml of precipitating agent 
acetonitrile was added and then centrifuged for 15 minutes at 5000 rpm. After centrifugation the 
clear supernatant liquid was collected and a quantity of 20µl was injected into the HPLC column 
and chromatograms were recorded. Standard calibration graph was plotted using ratio of peak 
area of Clotrimazole to its concentration. 
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ESTIMATION OF CLOTRIMAZOLE IN HUMAN PLASMA: 
Recording the chromatogram  
 
 The optimized chromatographic conditions were maintained to record the 
chromatograms of the calibration standards of Clotrimazole and sample from a clinical study. 
First, baseline stabilization was done for about 20 minutes. Then standard solutions, 
calibration standard solutions and sample from clinical study containing Clotrimazole were 
injected and chromatograms were recorded. 
 
VALIDATION OF THE METHOD  
 After developing a method its validation is necessary to prove the suitability of the 
method for the intended purpose. Here the procedure followed for the validation of the 
developed method is described.  
 
a) Precision: 
 Intraday and interday precision studies were conducted. In intraday precision plasma 
sample containing drug at three different concentrations with internal standard were injected 
and chromatogram was recorded. Similarly interday precision over a two week period time 
was evaluated. 
Acceptance criteria:  
 RSD of the mean concentration of five readings should be less than 15% for 
bioanalytical method. 
 
b) Accuracy: 
 It is the closeness of mean tests results obtained by the method to true concentration 
of analyte. It is also named as trueness. In this studies the selected concentration of the plasma 
were injected six times and mean peak area for each concentration was calculated. 
Concentration of the each injection was calculated and the standard deviation between the 
readings is calculated. To bioanalytical study the percentage RSD should be less than 15%.  
 Methodology 
 
Dept. of Analysis, KMCH College of Pharmacy Page 52 
 
 
 
 
c) Recovery studies: 
 The relative recovery of drug from plasma was calculated by comparing the readings 
of concentration obtained from the drug spiked plasma to that of equal concentration from 
standard sample.  Recovery studies were carried out six times for sample concentration at 
three levels within the calibration curve. 
Acceptance Criteria: 
                   For an assay method, mean recovery should be 85-105% ± 2%. 
 
d) Linearity and Range:  
 Linearity and range were estimated by using calibration curve. By using calibration 
standards prepared by spiking plasma (Clotrimazole) and internal standard (Ibuprofen) at 
different concentrations like 50ng/ml to 250ng/ml the calibration graph was plotted taking 
concentration of spiked plasma on x-axis and peak area on y-axis. The linearity is determined 
from 50% to 250% of the proposed concentration.  
 
Acceptance Criteria: 
                Coefficient of correlation of the calibration should be not less than 0.99 
e) Lower Limit of Quantification (LLOQ): 
 The LLOQ is determined by using the calibration curve. Limit of quantitation is the 
concentration of substance in the sample that will give a signal-to-noise ratio of 10:1. 
Detection limit corresponds to the concentration that will give a signal-to-noise ratio of 3:1. 
The signal to noise ratio were performed by comparing measured signal of blank plasma 
sample with those of known low concentration of drug. 
 
f) Specificity: 
 Specificity of the method was demonstrated by using diode array detector peak purity 
test. The diode array spectrum of both standard and sample peak were recorded and compared. 
The other way for doing specificity based in measurement of absorbance ratio of drug peaks at 
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two different levels. The retention time (Rt), resolution factor (Rs) and tailing (T) were noted 
for the peaks of Clotrimazole. Peak purity study is done to prove that a developed method is 
specific for the drug of interest. 
Acceptance criteria: 
             Purity angle should be less than purity threshold i.e.0.99-1.00 
 
h) Selectivity: 
 Selectivity is the analytical method ability to differentiate and quantify the analyte in 
the presence of other components in the sample. The selectivity was established by two 
different methods. 
 
Method I: Chromatograms of six blank plasma samples were compared with chromatogram 
obtained from standard solutions. Each chromatogram was tested for interferences due to 
endogenous plasma component on the retention times of the selected drugs. 
Method ІІ: This method involves the peak purity test method using diode array detector. The 
PDA spectrum, UV spectrum, absorbance ratio curve and first derivative spectrum of the 
standard and sample peaks was recorded using PDA detector and compared for the peak 
purity of drug. 
i) Robustness: 
 The robustness of the method was studied by changing the chromatographic 
conditions slightly. The standard solutions were injected in these changed chromatographic 
conditions.  
 ± 1 % difference in the ratio of acetonitrile in the mobile phase. 
 ± 0.5 difference in units of pH of the buffer. 
 ± 1 % difference in flow rate of the mobile phase.  
 
 In these changed conditions the separation factor, retention time and peak symmetry 
was calculated. Deviation in results from original run should be less than 2%. 
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j) System suitability studies: 
 In system suitability studies certain parameters were calculated namely, column 
efficiency, resolution, capacity factor by repeated injection of standard solutions. As specified 
in the USP these systems suitability studies were carried out. 
 
Capacity factor (k’) it is measurement of sample molecule how good is retained by a column 
during separation. The ideal k value ranges from 2-10. 
                                                Capacity Factor (k') = V1 – V0 / V0 
               Where, V1 is the retention volume at the apex of the peak (solute)   and V0 is the void 
volume of the system. 
 
Resolution (Rs) is the difference between the retention times of two solutes divided by their 
average peak width. The ideal value of (Rs) is 1.5 
Resolution (Rs) = Rt1 –Rt2 /0.5(W1-W2) 
Where, Rt1 and Rt2 are the retention times of component 1 and 2, respectively. 
 
Column Efficiency (N) of a column is measured by the number of theoretical plates per 
meter. For ideal good separation, column efficiency N value ranging from 5,000 to 100,000 
plates/meters. 
                                       Column efficiency (N) = Rt2 / W2 
 
                 Where Rt is the retention time and W is the peak width. 
 
Peak asymmetry factor- For better column performance it was calculated by the formula. 
When asymmetry factor of value 0.9 to 1.1 then it is achievable for a well packed column. 
                                                 Peak asymmetry factor (As) = b / a 
Where a and b are the distances on either side of the peak midpoint. 
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  Table No 2: System Suitability Parameters and Recommendations 
 
Parameter Recommendation 
Capacity Factor (k’) 
The peak should be well-resolved from other peaks and 
the void volume, generally k’ > 2.0 
 
Repeatability 
 
RSD < / = 1 % for N > / = 5 is desirable. 
Relative retention Not essential as long as the resolution is stated. 
Resolution (Rs) 
Rs of > 2 between the peak of interest and the closest 
eluting   potential   interferent   (impurity, excipient, 
degradation product, internal standard, etc.) 
Tailing Factor (T) T of < / = 2 
Theoretical Plates (N) 
 
In general should be > 2000 
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7. RESULTS AND DISCUSSION 
 
HIGH PERFORMANCE LIQUID CHROMATOGRAPHIC METHOD  
Bioanalytical method was developed for Clotrimazole and it was validated for its 
transferability.   
Chromatographic separation of standard Clotrimazole: 
        The chromatogram of Clotrimazole was recorded alone and shown in figure 
(Fig4).The standard solution which contains internal standard Ibuprofen was injected 
with the developed chromatographic conditions, and the chromatograms were recorded 
and shown in figure (Fig 5). 
 
 
Fig 4 - Chromatogram of standard Clotrimazole 10 µg/ml 
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     Fig 5 - Chromatogram of  Ibuprofen (50 µg/ml)  and standard      
     Clotrimazole 10 µg/ml 
 
           The retention time of Clotrimazole and internal standard (Ibuprofen) was 8.3 
and 5.2 min respectively with percent RSD of less than 2%. The results are shown in 
table (Table 1). The peak purity study reveals that signal ratios (relative absorbance at 
different wavelengths) were constant across the peak proﬁle of Clotrimazole. The 
peaks obtained in the present study were symmetric, good and no interference was 
observed between the peaks. 
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Table 1: Retention time of Clotrimazole and Ibuprofen (IS) 
 
      The method developed was advantageous than the reported methods by its lesser 
precision values and increased accuracy values.  
 
Chromatographic separation of Clotrimazole in biological fluid: 
 The chromatogram of the blank plasma was recorded at the fixed 
chromatographic conditions and shown in figure (Fig 6).  
 
 
Fig 6 - Chromatogram of blank plasma 
 
S. No Method 
Retention time of Drugs (min) 
Clotrimazole 
Internal Standard 
(Ibuprofen) 
 
1 
2 
3 
4 
5 
 
 
 
HPLC 
 
8.202 
8.356 
8.242 
8.254 
8.292 
 
5.264 
5.272 
5.279 
5.284 
5.296 
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 Various eluting solvents were used for extraction of Clotrimazole in human 
plasma. But, out of all eluting solvents acetonitrile-methanol mixture was proved to be 
good because of its maximum percentage recovery. The percentage recoveries were 
calculated and shown in table (Table 2). The retention time for Clotrimazole and internal 
standard (Ibuprofen) were 8.3 and 5.2 minutes respectively as shown in (Fig 5). The 
peaks were symmetric with straight baseline. 
Table 2: Recovery study of Clotrimazole 
S.No Conc. of 
drug 
added 
(ng/ml) 
Amt. of drug recovered from 
plasma (ng/ml) 
% Recovery 
ACN ACN and 
methanol 
mixture 
Ethyl 
acetate 
ACN ACN and 
methanol  
mixture 
Ethyl 
acetate 
I 50 43.2 46.4 48.4 84.2 91.8 86.4 
II 100 84.5 88.6 95.2 82.8 92.6 84.2 
III 150 124.1 132.4 147.6 83.5 89.9 87.3 
             *The mean of six value                                   
  
METHOD VALIDATION  
 
a) Accuracy and precision:  
 At two –levels these accuracy and precision studies were conducted i.e. intra-day 
and inter-day. In this the present developed method, shown the good accuracy and 
precision. Accuracy ranges from 99.99% to 100.4% with the precision 4.10% to 5.84% in 
intra-day method. In inter-day method the accuracy ranges from 99.7% to 101.07%   with 
the precision 6.65% to 7.88%.  Finally the data obtained here, was found to be within 
limits as per ICH guidelines and method was accurate.  
 
Intra-day studies: In this plasma concentration 50-150 ng/ml were injected six times 
and mean peak area was calculated separately for each concentration and from that 
accuracy and precision percentage RSD values were calculated and shown in table 
(Table 3)  
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Table 3: Accuracy and precision studies of Clotrimazole (Intraday) 
Sl.no 
Conc. of       
drug (ng/ml) 
Mean peak 
area 
 
Accuracy 
(%) 
RSD 
(%) 
 
 
1 
 
50 14927 99.99 4.10 
2 100 32163 101.2 5.84 
3 150 48063 100.4 4.45 
          * The mean of six value                                   
                               
 Inter-day studies: In this the plasma concentrations  of 50-150 ng/ml were 
injected into HPLC six times in three different days and mean peak areas were calculated 
and from that accuracy and precision  percentage RSD were calculated and shown in 
table (Table 4). The percentage relative standard deviation of precision for Clotrimazole 
was less than 15% for the bioanalytical study. The results obtained were within limits. 
 
Acceptance criteria: The percentage RSD value should be less than 15% for 
bioanalytical study. 
 
           Table 4:  Accuracy and precision studies of Clotrimazole (Interday) 
 
Sl.no 
Conc. of       
drug (ng/ml) 
Mean peak 
area 
 
Accuracy 
(%) 
RSD 
(%) 
 
1 50 14906 99.3 4.58 
2 100 32158 101.8 7.65 
3 150 48028 100.3 6.29 
       * The mean of six value      
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b) Linearity and range: 
 This method proved to be linear between50-250 ng/ml of Clotrimazole  in human 
plasma, with a typical calibration curve of correlation equation y = 0.021x-0.056, 
correlation coefficient > 0.999 shown in table (Table  5) 
 
Table 5:  Linearity range of Clotrimazole  
Concentration (ng/ml) Peak area of drug Peak area of IS 
 
Response 
factor 
 
0 
 
 
0 
 
 
 
 
 
 
15186 
 
0 
 
50 14927 0.983 
100 
32163 2.118 
150 48063 3.165 
200 64904 4.274 
250 82353 5.423 
 
 
  Calibration curve for Clotrimazole 
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 The chromatograms of the plasma calibration standards with concentrations 50, 
100, 150, 200 and 250 ng/ml were recorded and shown in figures (Fig 7,8,9,10 and 11) 
and their peak areas of both drug and internal standard were noted. The calibration curve 
for Clotrimazole was plotted as peak response Vs concentration of the Clotrimazole  
calibration standards in plasma . As we were using internal standard peak response was 
calculated for calibration curve. Peak response is the ratio of internal standard peak area 
to drug peak area. The correlation coefficient of Clotrimazole shown was 0.999 which 
was within limits. This calibration curve plotted was linear and showed that the method 
had adequate sensitivity to the concentration (50 ng/ml-250 ng/ml) of the drug. Finally 
the data obtained, in this was within limits. Coefficient of correlation of Clotrimazole  
was found to be less than 0.999. 
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Fig 7 - Chromatogram of IS(100ng/ml) and Clotrimazole (50ng/ml) in human 
plasma 
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Fig 8 - Chromatogram of Ibuprofen (100ng/ml) and Clotrimazole (100ng/ml) 
in human plasma 
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Fig 9 - Chromatogram of Ibuprofen (100ng/ml) and Clotrimazole (150ng/ml) in 
human plasma  
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    Fig 10- Chromatogram of Ibuprofen (100ng/ml) and Clotrimazole (200ng/ml) in 
human plasma  
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          Fig 11 - Chromatogram of Ibuprofen (100ng/ml) and Clotrimazole (250ng/ml) 
in human plasma  
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c) Lower Limit of Quantification and Limit of Detection: 
 The LOD is the smallest concentration of the analyte which shows a measurable 
response .The LOQ is the smallest concentration of the analyte, which shows response 
that can be accurately quantified LOD = 3.3 × D/S and LOQ = 10 × D/S, where, D is the 
standard deviation of y – intercepts of regression line and S is the slope of the calibration 
curve. This signal to noise ratio were performed by comparing measured signal of known 
low concentration of drug with those of blank plasma sample. 
 
 The Lower limit of quantification (LOQ) and limit of detection (LOD) for 
Clotrimazole were separately determined and reported, based on the calibration curve for 
spiked plasma solutions was found to be 23.90  ng/ml  and 7.8 ng/ml Srespectively.  
 
d) Recovery from plasma: 
 A recovery study for Clotrimazole in plasma using acetonitrile-methanol mixture 
was shown in table (Table 6). With concentrations 50 ng/ml, 100 ng/ml, 150 ng/ml of 
Clotrimazole recovery was calculated and showed 98.2%, 100.2%, 101.4% relative 
recoveries and percentage RSD as4.6%, 5.3% and 6.9% respectively.  
 
Acceptance criteria: For an assay method, mean recovery should be 85-105% ± 2%. 
 
Table 6: Recovery studies of Clotrimazole 
Levels 
Conc. of 
drug added 
(ng/ml) 
 
Amt of drug 
recovered in 
plasma sample 
(ng /ml) 
Percentage 
recovery 
(%) 
% RSD 
 
I 50 49.5 100.2 4.6 
II 100 98.9 98.2 6.9 
III 150 149.1 101.4 5.3 
       * The mean of six value  
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e) Ruggedness:  
 It expresses the precision within laboratories variations like different days, 
different analyst, and different equipments. Ruggedness of the method was assessed by 
spiking the plasma standard 6 times in two different days with different analyst and the 
standard deviation were analyzed by a different chemist and same instruments on a 
different day had been performed the reports were shown in table (Table  7). 
 
          The deviation among the results obtained by two chemists on a different day was 
well within the limits. Hence the method was rugged. 
 
Acceptance criteria: The percentage RSD should be less than 15%. 
 
Table 7:  Ruggedness studies for Clotrimazole 
Drug 
Concentration 
(ng/ml) 
Mean peak area %RSD 
 
 
 
Day I  analyst – I 
 
 
Clotrimazole 50 14910 4.267. 
 
 
Day II  analyst – II 
 
Clotrimazole 50 14908 4.148 
      * The mean of six value      
                             . 
f) Specificity: 
 For specificity the peak purity studies were done. Here for Clotrimazole the peak 
purity index was 000 and the peak properties like peak profile were good for both 
standard and the sample. The peak purity and peak profiles for Clotrimazole standard and 
sample were shown in figures (Fig 12, 13, 14, and 15) respectively. By the data obtained 
in this, the present method developed was specific as values were within limits.  
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Fig 12 - Peak profile of standard Clotrimazole 
 
Fig 13 - Peak profile of Clotrimazole in human plasma 
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                            Fig 14 - Peak purity of standard Clotrimazole 
 
 
 
                        Fig 15 - Peak purity of Clotrimazole in human plasma 
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g) System suitability: 
 These parameters were shown to be within specified limits. Column efficiency 
(theoretical plates), resolution factor and peak asymmetry factor, HETP, tailing factor, 
LOQ and LOD are the system suitability parameters. These parameters of the optimized 
methods were found satisfactory. The results of the system suitability studies in plasma 
were shown in table (Table 8). These parameters were shown to be within specified 
limits. 
 
Table 8: System suitability studies 
 
Sl.No Parameters 
 
Clotrimazole 
 
1. Theoretical Plate 6662 
2. Tailing Factor 1.1 
3. HETP 22.51 
4. LOQ 23.90 ng/ml 
5. LOD 7.8 ng/ml 
6. Resolution 5.8 
7. K                        2.83 
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8. SUMMARY AND CONCLUSION 
 A bioanalytical method was developed for the estimation of Clotrimazole by HPLC   
method. 
 The method was validated for its transferability to other user or other laboratory. 
 The HPLC method was developed by using 0.5%TEA in water (pH 3 adjusted with 
Orthophosphoric acid) and Acetonitrile in meticulous ratio. 
 The peaks obtained for the drugs of interest by the present method are well resolved from 
each other without any interference and from the plasma endogenous proteins.  
 The peaks are symmetrical with acceptable tailing factor.  
 The retention time of Clotrimazole was within the limit. 
 The results of linearity, intraday and interday precision study and capability of the 
extraction method were within the limits of bioanalytical method development.  
 The method was linear with a correlation coefficient of acceptable agreement, which is 
suitable for the estimation of Clotrimazole in human plasma and other biological fluids. 
 The method demonstrated relative recoveries with acceptable relative standard deviation.  
 The limit of quantification (LOQ) and limit of detection (LOD) for Clotrimazole was 
found to be nanograms lesser than unity. 
 Hence the developed method is sensitive for the estimation of Clotrimazole in trace 
amounts. 
 Peak purity studies, with peak purity index values closer to unity reveals that the method 
developed was specific for the estimation of Clotrimazole in blood and other biological 
fluids. 
 It can be concluded that the developed RP-HPLC method in human plasma was found to 
be very simple, reliable and selective for providing satisfactory accuracy and precision.  
 The methods are suitable for routine quantitative analysis in pharmaceutical dosage forms. 
Hence this developed method can be used further in  
o Bioequivalence and bioavailability studies of clotrimazole.   
o Pharmacokinetic and bio-equivalence study centers 
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ABSTRACT 
 
 
A sensitive and selective HPLC method for the estimation of Clotrimazole in human 
plasma was developed and validated. Sample preparation was carried out using protein 
precipitation method. Separation was done on a Enable C18 reverse phase column with 
a mobile phase of 0.5% TEA in water (pH 3 adjusted with o-phosphoric acid) and 
acetonitrile in the ratio of 20:80%v/v and detection at 215nm. The retention time of 5.2 
and 8.2mins for ibuprofen(IS) and clotrimazole  is highly advantageous. The standard 
curve is linear (r>0.999) over the concentration range of 50-250ng/ml. Validated 
analytical method was based on the parameters: selectivity, accuracy, precision, 
linearity, LOD, LOQ and the suitability of the system. Validation analysis showed 
selectivity test Rs.1.5, based on the area ratio of peak height and a segment of the 
chromatogram obtained LOD Value 7.8 ng/ml. LOQ value of 23.90ng/ml, percent 
accuracy from 99.5-100.3. For interday studies and 99.9-101.4 for intraday studies and 
precision 4.58-6.5 for interday studies and 4.10-5.84 for intraday studies. System 
suitability test results on the retention time, area ratio and peak ratios of peak 
chromatogram shows the CV(%)<10%. Thus it is concluded that the analytical methods 
used have validity in accordance with requirements. 
 
Keywords: RP-HPLC, Clotrimazole. Protein precipitation method,    Human plasma 
 
